Mediplantex National Pharmaceutical JSC

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 34.97% vs 0.27% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 56.99% vs 28.57% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "117,611.90",
          "val2": "87,136.70",
          "chgp": "34.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8,426.20",
          "val2": "7,179.70",
          "chgp": "17.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1,296.60",
          "val2": "555.80",
          "chgp": "133.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "6,139.30",
          "val2": "3,910.60",
          "chgp": "56.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "71.60%",
          "val2": "61.50%",
          "chgp": "1.01%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -17.16% vs 10.03% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 0.16% vs 29.83% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "367,081.40",
          "val2": "443,135.80",
          "chgp": "-17.16%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "28,191.90",
          "val2": "30,109.10",
          "chgp": "-6.37%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2,310.50",
          "val2": "3,787.30",
          "chgp": "-38.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "15,271.70",
          "val2": "15,246.80",
          "chgp": "0.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "57.50%",
          "val2": "50.10%",
          "chgp": "0.74%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

117,611.90

87,136.70

34.97%

Operating Profit (PBDIT) excl Other Income

8,426.20

7,179.70

17.36%

Interest

1,296.60

555.80

133.29%

Exceptional Items

0.00

0.00

Consolidate Net Profit

6,139.30

3,910.60

56.99%

Operating Profit Margin (Excl OI)

71.60%

61.50%

1.01%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 34.97% vs 0.27% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 56.99% vs 28.57% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

367,081.40

443,135.80

-17.16%

Operating Profit (PBDIT) excl Other Income

28,191.90

30,109.10

-6.37%

Interest

2,310.50

3,787.30

-38.99%

Exceptional Items

0.00

0.00

Consolidate Net Profit

15,271.70

15,246.80

0.16%

Operating Profit Margin (Excl OI)

57.50%

50.10%

0.74%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -17.16% vs 10.03% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 0.16% vs 29.83% in Dec 2024

All Annual Results